https://www.selleckchem.com/pr....oducts/Paclitaxel(Ta
The effects of coenzyme Q10 (CoQ1 supplementation in chronic kidney disease (CKD) patients remain controversial. A systematic review of current evidence was performed to systematically and comprehensively summarize the effects of CoQ10 on cardiovascular outcomes, oxidative stress, inflammation, lipid profiles, and glucose metabolism. MEDLINE, EMBASE, and the Cochrane Library database (Cochrane Central Register of Controlled Trials) were searched to identify eligible studies investigating the effects of CoQ10 supplementation
Like
Comment
Share
